Foxconn International, which is known as Hon Hai Precision Industry Co., Ltd. in China and Taiwan, has pulled out from its joint venture deal with Vedanta Limited, a leading natural resources conglomerate in India.
The Taiwanese semiconductor firm withdrew from its $19.5 billion project, and this turn of events was described as a huge blow to Prime Minister Narendra Modi's chip manufacturing plans for his country. According to Reuters, Foxconn did not say why it made this decision despite the fact that it already signed an agreement with Vedanta last year to build a chip and display manufacturing facility in India’s state of Gujarat.
Moreover, it was reported that the country’s prime minister has made chipmaking a top priority as part of his economic strategy for India. He is pushing forward with his plan of making a "new era in electronics manufacturing, but with Foxconn's withdrawal, his ambition of attracting foreign investors for chip production has been shattered. This would have been the very first local chip production in India, but the project has failed.
"Foxconn has determined it will not move forward on the joint venture with Vedanta,” the chip maker said in a statement regarding its pull out from the chipmaking joint venture. “Foxconn is working to remove the Foxconn name from what now is a fully-owned entity of Vedanta."
CNBC reported that Foxconn said its move to drop out was a “mutual agreement” with Vedanta. While it will no longer continue with the JV, it remained confident that India will be able to achieve its semiconductor ambitions.
Foxconn is a known supplier of chips, and Apple is one of its major clients. It is working to further its reach and diversify its supply chains beyond mainland China. It was noted that the company already has several factories across India, but its canceled venture with Vedanta would have been one of its largest projects.
Photo by: Vishnu Mohanan/Unsplash


Oil Prices Hold Near Multi-Year Highs Amid Iran Conflict and Hormuz Supply Fears
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
RBI Clamps Down on Rupee NDF Activity, Banks Face Steeper Losses
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Oil Prices Slide as Iran Tensions Ease and U.S. Crude Stockpiles Swell
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Trump Expands Tariffs on Pharmaceuticals and Metals One Year After Liberation Day
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
U.S. Job Market Braces for Slow Recovery Amid Middle East Tensions and Economic Uncertainty
Japan Signals Readiness to Intervene as Yen Weakens Toward 160 Per Dollar
Australia's Trade Surplus Surges in February on Gold Export Boom
Apple Turns 50: From Garage Startup to AI Crossroads
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Bank of Japan Eyes Further Rate Hikes Amid Middle East Tensions and Inflation Pressures 



